← Leaderboards
David M Herrington
Wake Forest University
$40,002,179
Attributed
$41,252,931
Total exposure
19
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$41,252,931 · 19
By mechanism
R01$24,210,444 · 7
U01$8,668,720 · 1
T32$7,897,467 · 1
M01$332,272 · 8
R03$129,028 · 1
R13$15,000 · 1
Top collaborators
- Donald W. Bowden4 shared
Most similar at Wake Forest University
Same institution · by research overlap
- Donald W. Bowden$36,211,199
- John S Parks$14,793,642
- Dixon M Moody$6,559,201
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisClinical ResearchGenotypeEstrogensTraining ProgramsEpidemiologyFemalePathway InteractionsHormone TherapyHuman SubjectHuman Therapy EvaluationBaseCardiovascular SystemPostmenopauseSamplingWomen'S HealthVariantGeneticCardiovascular DiseasesInsightGenome Wide Association StudyDatabasesMass Spectrum AnalysisCollaborations
Grant awards (66)
CVD Epidemiology Training Program$565,566
T32 · FY2025 · HL · contact PI
CVD Epidemiology Training Program$288,063
T32 · FY2024 · HL · contact PI
CVD Epidemiology Training Program$536,402
T32 · FY2023 · HL · contact PI
CVD Epidemiology Training Program$524,230
T32 · FY2022 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,113,515
R01 · FY2021 · HL · contact PI
CVD Epidemiology Training Program$252,513
T32 · FY2021 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,088,693
R01 · FY2020 · HL · contact PI
CVD Epidemiology Training Program$397,755
T32 · FY2020 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,083,992
R01 · FY2019 · HL · contact PI
Metabolomic Signatures of CAD Associated Genotypes$587,948
R01 · FY2019 · HL · contact PI
CVD Epidemiology Training Program$496,252
T32 · FY2019 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,158,706
R01 · FY2018 · HL · contact PI
Metabolomic Signatures of CAD Associated Genotypes$603,562
R01 · FY2018 · HL · contact PI
CVD Epidemiology Training Program$479,585
T32 · FY2018 · HL · contact PI
Metabolomic Signatures of CAD Associated Genotypes$622,461
R01 · FY2017 · HL · contact PI
CVD Epidemiology Training Program$466,222
T32 · FY2017 · HL · contact PI
Metabolomic Signatures of CAD Associated Genotypes$687,534
R01 · FY2016 · HL · contact PI
CVD Epidemiology Training Program$459,457
T32 · FY2016 · HL · contact PI
Multi-Block Latent Variable Models for Statistical Integration of Multi-Platform Metabolomic Data$129,028
R03 · FY2016 · CA · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,031,742
R01 · FY2015 · HL · contact PI
CVD Epidemiology Training Program$229,778
T32 · FY2015 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,216,249
R01 · FY2014 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,177,060
R01 · FY2013 · HL · contact PI
CVD Epidemiology Training Program$284,046
T32 · FY2013 · HL · contact PI
Genomic and Proteomic Architecture of Atherosclerosis$2,340,070
R01 · FY2012 · HL · contact PI
CVD Epidemiology Training Program$380,594
T32 · FY2012 · HL · contact PI
CVD Epidemiology Training Program$418,640
T32 · FY2011 · HL · contact PI
CVD Epidemiology Training Program$412,536
T32 · FY2010 · HL · contact PI
SNPs and Extent of Atherosclerosis (SEA) Study$1,961,748
U01 · FY2009 · HL · contact PI
Machine Learning to Identify Complex Interactions in Genome-Wide Association Data$398,074
R01 · FY2009 · HL · contact PI
CVD Epidemiology Training Program$348,137
T32 · FY2009 · HL · contact PI
SNPs and Extent of Atherosclerosis (SEA) Study$1,760,405
U01 · FY2008 · HL · contact PI
Machine Learning to Identify Complex Interactions in Genome-Wide Association Data$398,794
R01 · FY2008 · HL · contact PI
CVD Epidemiology Training Program$285,037
T32 · FY2008 · HL · contact PI
SNPs and Extent of Atherosclerosis (SEA) Study$2,592,620
U01 · FY2007 · HL · contact PI
Machine Learning to Identify Complex Interactions in Genome-Wide Association Data$399,537
R01 · FY2007 · HL · contact PI
CVD Epidemiology Training Program$285,853
T32 · FY2007 · HL · contact PI
SNPs and Extent of Atherosclerosis (SEA) Study$2,353,947
U01 · FY2006 · HL · contact PI
CVD Epidemiology Training Program$359,772
T32 · FY2006 · HL · contact PI
CVD Epidemiology Training Program$285,853
T32 · FY2005 · HL
Estrogen Receptor Variants,HDL, and Atherosclerosis$271,740
R01 · FY2005 · HL
Estrogen Receptor Variants, HDL, &Atherosclerosis$534,009
R01 · FY2004 · HL
Thrombosis Gene Polymorphisms and Early CHD Risk in HERS$336,382
R01 · FY2004 · HL
Estrogen Receptor Variance and CHD Risk in HERS$269,982
R01 · FY2004 · HD
CVD Epidemiology Training Program$141,176
T32 · FY2004 · HL
Thrombosis Gene Polymorphisms and Early CHD Risk in HERS$358,333
R01 · FY2003 · HL
Estrogen Receptor Variance and CHD Risk in HERS$315,450
R01 · FY2003 · HD
Thrombosis Gene Polymorphisms and Early CHD Risk in HERS$335,818
R01 · FY2002 · HL
Estrogen Receptor Variance and CHD Risk in HERS$301,647
R01 · FY2002 · HD
LDL CHOLESTEROL LOWERING BEYOND CURRENTLY RECOMMENDED MINIMUM TARGETS$143,176
M01 · FY2002 · RR
POSTMENOPAUSAL HRT AFTER CORONARY BYPASS SURGERY (EAGAR)$0
M01 · FY2002 · RR
NUTRIENT-SUPPLEMENT MEDICAL FOOD IN HYPERCHOLESTROLEMIA (HEARTBAR STUDY)$0
M01 · FY2002 · RR
RALOXIFENE OR PLACEBO IN POSTMENOPAUSAL WOMEN AT RISK FOR CARDIOVASCU$0
M01 · FY2002 · RR
BRACHIAL ARTERY DILATATION MEASUREMENTS TO ASSESS ENDOTHELIAL FUNCTIO$0
M01 · FY2002 · RR
ESTROGEN AND ATHEROSCLEROSIS IN OLDER WOMEN (ERA)$0
M01 · FY2002 · RR
ESTROGEN, INFLAMMATION AND ATHEROSCLEROSIS$216,750
R01 · FY2001 · HL
ESTROGEN, INFLAMMATION AND ATHEROSCLEROSIS$362,396
R01 · FY2000 · HL
ESTROGEN AND ATHEROSCLEROSIS IN OLDER WOMEN (ERA)$38,800
M01 · FY2000 · RR
POSTMENOPAUSAL HRT AFTER CORONARY BYPASS SURGERY (EAGAR)$38,800
M01 · FY2000 · RR
HEART AND ESTROGEN/PROGESTIN REPLACEMENT STUDIES$38,800
M01 · FY2000 · RR
RALOXIFENE OR PLACEBO IN POSTMENOPAUSAL WOMEN AT RISK FOR CARDIOVASCU$24,232
M01 · FY2000 · RR
LDL CHOLESTEROL LOWERING BEYOND CURRENTLY RECOMMENDED MINIMUM TARGETS$24,232
M01 · FY2000 · RR
BRACHIAL ARTERY ENDOTHELIUM DEPENDENT VASODILATION$24,232
M01 · FY2000 · RR
GRAYLYN CONFERENCE ON WOMEN'S HEALTH$15,000
R13 · FY2000 · AG
BRACHIAL ARTERY DILATATION MEASUREMENTS TO ASSESS ENDOTHELIAL FUNCTIO$0
M01 · FY2000 · RR
NUTRIENT-SUPPLEMENT MEDICAL FOOD IN HYPERCHOLESTROLEMIA (HEARTBAR STUDY)$0
M01 · FY2000 · RR